Induced pluripotent stem cells from ALS patients for disease modeling

Jean-Philippe Richard, Nicholas J Maragakis

Research output: Contribution to journalArticle

Abstract

The ability to reprogram adult somatic cells into pluripotent stem cells that can differentiate into all three germ layers of the developing human has fundamentally changed the landscape of biomedical research. For a neurodegenerative disease like Amyotrophic Lateral Sclerosis (ALS), which does not manifest itself until adulthood and is a heterogeneous disease with few animal models, this technology may be particularly important. Induced pluripotent stem cells (iPSC) have been created from patients with several familial forms of ALS as well as some sporadic forms of ALS. These cells have been differentiated into ALS-relevant cell subtypes including motor neurons and astrocytes, among others. ALS-relevant pathologies have also been identified in motor neurons from these cells and may provide a window into understanding disease mechanisms in vitro. Given that this is a relatively new field of research, numerous challenges remain before iPSC methodologies can fulfill their potential as tools for modeling ALS as well as providing a platform for the investigation of ALS therapeutics. This article is part of a Special Issue entitled ALS complex pathogenesis.

Original languageEnglish (US)
Pages (from-to)15-25
Number of pages11
JournalBrain Research
Volume1607
DOIs
StatePublished - May 14 2015

Fingerprint

Induced Pluripotent Stem Cells
Amyotrophic Lateral Sclerosis
Motor Neurons
Germ Layers
Pluripotent Stem Cells
Astrocytes
Neurodegenerative Diseases
Biomedical Research
Animal Models
Pathology
Technology
Research

Keywords

  • Astrocyte
  • Human
  • iPSC
  • Motor neuron
  • Non-cell autonomous
  • Stem cell

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Induced pluripotent stem cells from ALS patients for disease modeling. / Richard, Jean-Philippe; Maragakis, Nicholas J.

In: Brain Research, Vol. 1607, 14.05.2015, p. 15-25.

Research output: Contribution to journalArticle

@article{c8ae60ed4c6b4c0692a444635d618072,
title = "Induced pluripotent stem cells from ALS patients for disease modeling",
abstract = "The ability to reprogram adult somatic cells into pluripotent stem cells that can differentiate into all three germ layers of the developing human has fundamentally changed the landscape of biomedical research. For a neurodegenerative disease like Amyotrophic Lateral Sclerosis (ALS), which does not manifest itself until adulthood and is a heterogeneous disease with few animal models, this technology may be particularly important. Induced pluripotent stem cells (iPSC) have been created from patients with several familial forms of ALS as well as some sporadic forms of ALS. These cells have been differentiated into ALS-relevant cell subtypes including motor neurons and astrocytes, among others. ALS-relevant pathologies have also been identified in motor neurons from these cells and may provide a window into understanding disease mechanisms in vitro. Given that this is a relatively new field of research, numerous challenges remain before iPSC methodologies can fulfill their potential as tools for modeling ALS as well as providing a platform for the investigation of ALS therapeutics. This article is part of a Special Issue entitled ALS complex pathogenesis.",
keywords = "Astrocyte, Human, iPSC, Motor neuron, Non-cell autonomous, Stem cell",
author = "Jean-Philippe Richard and Maragakis, {Nicholas J}",
year = "2015",
month = "5",
day = "14",
doi = "10.1016/j.brainres.2014.09.017",
language = "English (US)",
volume = "1607",
pages = "15--25",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Induced pluripotent stem cells from ALS patients for disease modeling

AU - Richard, Jean-Philippe

AU - Maragakis, Nicholas J

PY - 2015/5/14

Y1 - 2015/5/14

N2 - The ability to reprogram adult somatic cells into pluripotent stem cells that can differentiate into all three germ layers of the developing human has fundamentally changed the landscape of biomedical research. For a neurodegenerative disease like Amyotrophic Lateral Sclerosis (ALS), which does not manifest itself until adulthood and is a heterogeneous disease with few animal models, this technology may be particularly important. Induced pluripotent stem cells (iPSC) have been created from patients with several familial forms of ALS as well as some sporadic forms of ALS. These cells have been differentiated into ALS-relevant cell subtypes including motor neurons and astrocytes, among others. ALS-relevant pathologies have also been identified in motor neurons from these cells and may provide a window into understanding disease mechanisms in vitro. Given that this is a relatively new field of research, numerous challenges remain before iPSC methodologies can fulfill their potential as tools for modeling ALS as well as providing a platform for the investigation of ALS therapeutics. This article is part of a Special Issue entitled ALS complex pathogenesis.

AB - The ability to reprogram adult somatic cells into pluripotent stem cells that can differentiate into all three germ layers of the developing human has fundamentally changed the landscape of biomedical research. For a neurodegenerative disease like Amyotrophic Lateral Sclerosis (ALS), which does not manifest itself until adulthood and is a heterogeneous disease with few animal models, this technology may be particularly important. Induced pluripotent stem cells (iPSC) have been created from patients with several familial forms of ALS as well as some sporadic forms of ALS. These cells have been differentiated into ALS-relevant cell subtypes including motor neurons and astrocytes, among others. ALS-relevant pathologies have also been identified in motor neurons from these cells and may provide a window into understanding disease mechanisms in vitro. Given that this is a relatively new field of research, numerous challenges remain before iPSC methodologies can fulfill their potential as tools for modeling ALS as well as providing a platform for the investigation of ALS therapeutics. This article is part of a Special Issue entitled ALS complex pathogenesis.

KW - Astrocyte

KW - Human

KW - iPSC

KW - Motor neuron

KW - Non-cell autonomous

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=84926168917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926168917&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2014.09.017

DO - 10.1016/j.brainres.2014.09.017

M3 - Article

C2 - 25223906

AN - SCOPUS:84926168917

VL - 1607

SP - 15

EP - 25

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -